Adipose tissue structure is altered during obesity, leading to deregulation of whole-body metabolism. Its function depends on its structure, in particular adipocytes number and differentiation stage. To better understand the mechanisms regulating adipogenesis, we have investigated the role of an endoribonuclease, endoribonuclease L (RNase L), using wild-type and RNase L-knockout mouse embryonic fibroblasts (RNase L À/À -MEFs). Here, we identify C/EBP homologous protein 10 (CHOP10), a dominant negative member of the CCAAT/enhancer-binding protein family, as a specific RNase L target. We show that RNase L is associated with CHOP10 mRNA and regulates its stability. CHOP10 expression is conserved in RNase L À/À -MEFs, maintaining preadipocyte state while impairing their terminal differentiation. RNase L À/À -MEFs have decreased lipids storage capacity, insulin sensitivity and glucose uptake. Expression of ectopic RNase L in RNase L À/À -MEFs triggers CHOP10 mRNA instability, allowing increased lipids storage, insulin response and glucose uptake. Similarly, downregulation of CHOP10 mRNA with CHOP10 siRNA in RNase L À/À -MEFs improves their differentiation in adipocyte. In vivo, aged RNase L À / À mice present an expanded adipose tissue, which, however, is unable to correctly store lipids, illustrated by ectopic lipids storage in the liver and in the kidney. These findings highlight RNase L as an essential regulator of adipogenesis via the regulation of CHOP10 mRNA.
In the past 50 years, the incidence of obesity and related metabolic disorders has increased markedly, reaching a worldwide epidemic scale. Obesity is associated with several health problems, including insulin resistance, type 2 diabetes, fatty liver disease, atherosclerosis, degenerative disorders, airway diseases and some cancers.
Obese individuals suffer from a higher adiposity level resulting from an increased adipocytes number (hyperplasia) and/or size (hypertrophy). 1 Adipose tissue is involved in metabolic regulation and particularly lipids storage, insulin sensitivity and glucose uptake. 2 It has therefore a central role in controlling whole-body glucose and lipids homeostasis. Adipose tissue functions depend on its structure defined by adipocytes number and differentiation stage; this structure is altered during obesity. 3 Understanding the mechanisms implicated in the regulation of adipocyte differentiation should help elucidate adipose tissue development and its link to metabolic diseases.
After activation by various factors, such as hormones, adipogenesis occurs in successive phases leading from preadipocytes to mature adipocytes. Particularly, the expansion phase of preadipocytes precedes their differentiation to adipocytes. 4, 5 Like other differentiation pathways, adipogenesis involves sequential and orderly expression of many factors triggering a whole activation/inactivation cascade of genes expression. Among the several transcription factors known to have a significant role in promoting adipogenesis, two of them have a central role by regulating several downstream target genes: the CCAAT/enhancer-binding protein a (C/EBPa) and the nuclear receptor peroxisome proliferator-activated receptor g2 (PPARg2). C/EBPa and PPARg2 expression and activity are required for the adipose tissue development, insulin sensitivity and maintenance of mature adipocyte functions, such as triglycerides synthesis and storage. Their expression is closely regulated at different levels; in particular, their transcription is regulated by other members of the C/EBP family (b,d), 6 which expression precedes the induction of C/EBPa and PPARg2. Terminal adipogenesis is also regulated by another C/EBP family member named C/EBP homologous protein 10 (CHOP10). By forming heterodimers with other C/EBPs, CHOP10 functions as a dominant negative member of the C/EBP family. In preadipocytes, it forms a heterodimer with C/EBPb, inhibiting its DNA-binding activity. This inhibition of C/EBPb is As now demonstrated by several studies, an essential mechanism of gene expression control is through mRNA stability regulation. 10, 11 One nuclease firmly implicated in cellular mRNA stability is the endoribonuclease L (RNase L). 12 RNase L is an ubiquitous endoribonuclease, which activity is strictly dependent on an oligoadenylate, the 2-5A, synthesized by the 2-5A synthetase(s). 12, 13 RNase L regulates mRNAs stability during their translation and its activity is negatively regulated by RLI (RNase L inhibitor). [14] [15] [16] We have previously shown that RNase L and its inhibitor RLI are induced during differentiation and control gene expression and cell fate during myogenesis. 11, 17 Transcriptome analysis of myoblasts overexpressing RNase L allowed us to identify some mRNA targets of RNase L, among which CHOP10 mRNA. 11 As CHOP10 is a conductor of adipogenesis, 7 we were interested in studying the role of RNase L in adipogenesis and insulin sensitivity. Hence, we used wild-type (WT) and RNase L-knockout mouse embryonic fibroblasts (MEFs), 18 adipogenesis of MEFs induced by hormonal treatment being a well-established model system for the study of adipocyte differentiation. 19 Here, we show that RNase L directly regulates CHOP10 mRNA. Indeed, we demonstrate that RNase L is associated with CHOP10 mRNA and controls CHOP10 expression by regulating its mRNA stability. As CHOP10 expression is maintained after induction of adipocyte differentiation in RNase L À/À -MEFs, this leads to the impairment of terminal adipocyte differentiation, the decrease in insulin sensitivity and glucose uptake, and to increased ROS production. Conversely, expression of ectopic human RNase L (Hu-RNase L) or transfection of CHOP10-siRNA (siCHOP) in RNase L À/À -deficient cells triggers CHOP10 mRNA instability, decreases ROS level and allows an increase in lipids storage, insulin response and glucose uptake. Consolidating these results, RNase L À/À mice present an expansion of their adipose tissue (hyperplasia) and a defect in lipids storage. Our results highlight RNase L as an essential regulator of the adipogenesis processes and insulin response by regulating CHOP10 mRNA stability.
Results
Lack of RNase L impairs adipogenesis. MEFs are interesting cell models to study the specific role of a factor during adipogenesis, as they can differentiate into mature adipocytes after hormonal stimulation. 19 To explore RNase L function during adipogenesis at a molecular level, we used WT-MEFs and RNase L-knockout MEFs (RNase L À/À -MEFs). 18 RNase L À/À -MEFs did not express mouse RNase L protein, as the first exon of RNase L gene was deleted in the RNase L À/À mouse. 18 However, these cells expressed an equivalent level of RLI as WT-MEFs ( Figure 1A ). WT-MEFs and RNase L À/À -MEFs present the same viability under our experimental conditions, as shown in Figure 1B .
First, we compared lipids accumulation in WT-MEFs and RNase L À/À -MEFs before and after adipocyte differentiation. If WT-MEFs and RNase L À/À -MEFs both increased their lipids content after differentiation ( Figure 1C , compare a and e to b and f, respectively), their lipids staining with oil red O showed a very different pattern. Indeed, when observed at a lower magnification, lipids staining in WT-MEFs was not uniform, small groups of highly labeled cells being separated by unlabeled cells (Figure 1C, c) . On the other hand, lipids staining in RNase L À/À -MEFs revealed a low but uniform labeling of cells, indicating that more cells accumulated lipids ( Figure 1C, d) . However, observation of lipids staining at a greater magnification showed that RNase L À/À -MEFs accumulated smaller lipid droplets than WT-MEFs ( Figure 1C , compare e and f). This difference in lipids accumulation was confirmed by quantification: RNase L À/À -MEFs accumulated 1.7 time lesser lipids than WT-MEFs ( Figure 1D ). This impairment in lipids storage, a major adipocyte function, was confirmed by studying expression of two proteins specifically expressed in mature adipocytes: adipocyte protein 2 (aP2)/ fatty acid-binding protein 4 (Fabp4), involved in intracellular lipids trafficking, 20 and perilipin, a lipid droplet-associated protein 21 ( Figure 2A ). As illustrated in Figure 2A , aP2/Fabp4 is less expressed in RNase L À/À -MEFs than in WT-MEFs (compare Figure 2A, a and b) . Surprisingly, even if we observed an increase in lipids accumulation after differentiation of RNase L À/À -MEFs ( Figures 1C and D) , we were unable to detect perilipin surrounding lipid droplets in these cells (compare Figure 2A, c and d) . The same result was obtained by western blot, using an anti-perilipin antibody (data not shown). These results indicated impairment in lipids accumulation and storage in RNase L À/À -MEFs.
Genes expression during adipocyte differentiation. Adipogenesis involves a differentiation switch that activates a new program of gene expression. As previously shown during myoblast differentiation, 11 RNase L activity is induced throughout adipocyte differentiation of WT-MEFs. Indeed, OAS2 (oligoadenylate synthetase 2) mRNA is induced ( Figures 2B and C) ; OAS2 synthesizes the 2-5A allowing RNase L activation. 12, 13 In parallel, RLI mRNA expression is decreased 6 days after induction of adipocyte differentiation. To explore the molecular basis through which RNase L deficiency impairs adipogenesis, we also followed expression levels of mRNAs coding for factors involved in adipogenesis (C/EBPa, CHOP10 and PPARg2), lipids metabolism (aP2/Fabp4) and insulin response (Glut4: glucose transporter 4; Figures 2B and C) . The expression profiles of these mRNAs during the differentiation were modified in RNase L À/À -MEFs compared with WT-MEFs. Induction of C/EBPa, aP2/Fabp4 and PPARg2 was much lower in RNase L À/À -MEFs. Importantly, Glut4 mRNA was not induced in the absence of RNase L but increased 410 times in WT-MEFs. Contrarily, CHOP10 mRNA expression was maintained at a high level during the differentiation in RNase L À/À -MEFs as it declined 470% in WT-MEFs from confluence to day 6 of differentiation ( Figures 2B and C) .
RNase L disruption leads to adipocyte dysfunction O Fabre et al ROS production. In RNase L À/À -MEFs, we noted a higher CHOP10 expression than in WT-MEFs ( Figures 2B and C) . This constant expression of CHOP10 could favor increased ROS production. 22, 23 Indeed, as shown in Figure 2D , the level of ROS was significantly higher in RNase L À/À -MEFs compared with WT-MEFs.
RNase L is associated with CHOP10 messengerribonucleoprotein complex (mRNP) and regulates CHOP10 mRNA stability. We were particularly interested in the differential CHOP10 mRNA expression that we noticed between WT-MEFs and RNase L À/À -MEFs, CHOP10 being, as described in the introduction, an essential regulator of adipogenesis. RNase L has no great sequence specificity and cleaves single-stranded RNA at UpNp sequences. 12 Moreover, RNase L has no specific RNA recognition motif sequence allowing its direct interaction with mRNA. However, we have previously shown that RNase L could participate to mRNPs via its interaction with RNA-binding proteins. 15 To analyze if RNase L is associated with mRNP containing CHOP10 mRNA, we immunoprecipitated cytoplasmic mRNPs with a specific monoclonal antibody raised against RNase L in RNase L À/À -MEFs and WT-MEFs cell extracts. By real-time quantitative PCR (q-PCR), we could specifically amplify and detect CHOP10 mRNA in the mRNPs immunoprecipitated with a specific antibody against RNase L (Figure 3a) . The presence of RNase L protein associated with CHOP10 mRNA was only observed in WT-MEFs and no interaction between RNase L and CHOP10 mRNA could be identified without any antibody or using an irrelevant antibody (a-tubulin; Figure 3a) . These results confirmed the specificity of the constated interaction. To confirm that RNase L regulates CHOP10 mRNA stability, we then compared CHOP10 mRNA stability in WT-MEFs and RNase L À/À -MEFs after transcription inhibition by the actinomycin D treatment. In RNase L À/À -MEFs, we clearly observed a stabilization of CHOP10 mRNA compared with WT-MEFs (Figures 3b and c) . (Figures 4a and b) . Akt phosphorylation is crucial for the intracellular signal transduction of insulin leading to glucose uptake by adipocytes. 24 Measurement of glucose uptake in RNase L À/À -MEFs also showed a defect in insulin response of these cells compared with WT-MEFs (Figure 4c ). Indeed, no increase in glucose uptake after insulin treatment of RNase L À/À -MEFs was observed while it was increased two times in WT-MEFs after insulin treatment. Glucose uptake Figures 7D and E) . However, this result was not statistically significant. The latter could be because of the difficulty to obtain sufficient cells transfected with siCHOP. Nevertheless, these results clearly showed that CHOP10 mRNA downregulation is necessary to allow complete adipocyte differentiation of MEFs.
Discussion
Adipose tissue has a central role in metabolic regulations, partly due to its capacity to store lipids. Adipogenesis is controlled by several functionally coherent mechanisms, which are intricately coordinated and regulated in time to ensure the activation/inactivation cascade of genes expression. The transition from preadipocyte to mature adipocyte involves successive stages: growth arrest, clonal expansion and differentiation. The clonal expansion phase is necessary for terminal differentiation. These different steps are predominantly regulated by C/EBP family members and PPARg.
Regulation of mRNA stability is an essential mechanism for controlling genes expression. 10, 11 Cytoplasmic mRNAs are engaged in mRNA/proteins complexes called mRNPs, which have a major role in mRNA translation and stability. 25 Here, we show that an endoribonuclease, RNase L, directly regulates mRNA stability of CHOP10, a member of the C/EBP family and a fundamental regulator of adipogenesis. RNase L has no great sequence specificity and cleaves single-stranded RNA at UpNp sequences. 12 RNase L specificity is above all due to its interaction with transacting factors, such as eukaryotic releasing factor 3 15 and mitochondrial initiation factor 2. 16 In this study, we show for the first time that RNase L interacts with CHOP10 mRNA in mRNPs. Indeed, a specific monoclonal antibody directed against RNase L immunoprecipitated RNase L protein associated with CHOP10 mRNA only in WT-MEFs, while no RNase L-CHOP10 mRNA interaction was detected in RNase L À/À -MEFs. Association of RNase L with CHOP10 mRNA in mRNP enables CHOP10 mRNA regulation by RNase L, as illustrated by the preservation of CHOP10 mRNA expression in RNase L À/À -MEFs when it strongly decreases in WT-MEFs during adipocyte differentiation.
CHOP10 interacts with another member of the C/EBP family, C/EBPb, by inhibiting its transcriptional activity. This inhibition is necessary for clonal expansion of preadipocytes, a prerequisite to adipocyte differentiation. 7 As CHOP10 expression decreases, C/EBPb is released, allowing transactivation of C/EBPa and terminal adipocyte differentiation. Maintaining CHOP10 expression could lead to an excessive clonal expansion (hyperplasia), at the expense of late differentiation and lipids storage capacity of mature adipocytes. Here, we show that terminal adipocyte differentiation is impaired in RNase L À/À -MEFs. In fact, these cells accumulated fewer lipids than WT-MEFs. Moreover, RNase L À/À -MEFs expressed a lower level of aP2/Fabp4, indicating a dysfunction of intracellular lipids trafficking. 20 Beside, we failed to detect perilipin at the surface of lipid droplets of RNase L À/À -MEFs. In RNase L À/À -MEFs, CHOP10 expression was maintained even after induction of differentiation, leading to lower induction of C/EBPa and PPARg2 expression. Therefore, as terminal adipocyte differentiation could not correctly proceed, we observed more adipocytes with small lipid droplets while lipids accumulation, Glut4 mRNA expression and insulin response were lower in these cells than in WT-MEFs. On the other hand, it has been shown in different cell systems that overexpression of CHOP10 leads to an increased ROS production. 26 ROS, in turn, could induce CHOP10 expression. 27 Actually, in RNase L À/À -MEFs cells, we noticed an increase in ROS level. Several studies relating to the consequences of ROS production have been performed and contradicting effects have been reported. Some studies describe ROS as positive regulators of adipocyte differentiation by accelerating mitotic clonal expansion 28 and enhancing insulin sensitivity. 29 Conflictingly, other studies present ROS as inhibitors of adipocyte differentiation by regulating CHOP10 expression 27 and inhibiting insulin response 22 and Glut4 expression. 30 The apparent discrepancies between these different studies reflect how the level and kinetics of ROS expression have vital effects on cell fate. 9 Here, we showed higher ROS level in RNase L À/À -MEFs with a decrease in insulin signaling, which participated in insulinstimulated glucose uptake inhibition. The lower level of Glut4 expression in RNase L À/À -MEFs could also favor the restricted glucose uptake.
To confirm the essential role of RNase L in CHOP10 mRNA regulation and adipogenesis, we re-introduced RNase L expression in RNase L À/À -MEFs. In these cells, which express Hu-RNase L (Hu-RNase L À/À -MEFs), CHOP10 mRNA stability was highly reduced compared with RNase L À/À -MEFs transfected with a control vector (V-RNase L À/À -MEFs). This also led to a decreased CHOP10 mRNA expression after induction of adipocyte differentiation and to higher levels of C/ EBPa, PPARg2, aP2/Fabp4 and Glut4 mRNAs expression. Moreover, in Hu-RNase L À/À -MEFs, ROS level were decreased by 50%, while lipids accumulation was increased by 75%. Finally, insulin response and glucose uptake were also significantly improved after re-expression of RNase L in Fold induction of glucose uptake -MEFs, and RNase L activity could only be regulated by OAS2 expression, 2-5A synthesis and RLI.
To confirm the effects observed following the overexpression of CHOP10 on RNase L À/À -MEFs differentiation inhibition, we downregulated CHOP10 mRNA in RNase L À/À -MEFs by CHOP10 siRNA (siCHOP) transfection. Even if not all cells were transfected with siCHOP, we notified a significant downregulation of CHOP10 mRNA expression, which was accompanied by improved adipocyte differentiation. Our results clearly identify RNase L as an essential effector of terminal adipocyte differentiation by regulating CHOP10 level.
Maintaining a high level of CHOP10 expression in vivo could lead to an excessive clonal expansion (hyperplasia) of developing adipocytes at the expense of late differentiation and lipids storage capacity of mature adipocytes. 5 Actually, RNase L À/À mice possess a higher number of smaller adipocytes than WT mice ( Figure 8A) , that is characteristic of hyperplasia. 31 This number of adipocytes increases with aging, as we observed an adipose tissue expansion in aged RNase L À/À mice. The average body weight of aged RNase -MEFs were induced to differentiate in ADM. mRNAs were extracted at confluence (C) and at days 3 (3d) and 6 (6d) after switch to ADM. After RT and PCR amplification using specific primers (Supplementary Table 1 Figure 8C ). Interestingly, adipose tissue expansion is observed in aged RNase L À/À mice and not in young mice. At present, it is known that CHOP10 is more expressed in old individuals preadipocytes than from young ones. 5 Change in adipogenesis process is due to the incapacity of preadipocytes to express appropriate levels of key adipogenic regulators: CHOP10, C/EBPa and PPARg. 4, 32 We assume that overexpression of CHOP10 in RNase L À/À mice added to the physiological overexpression of CHOP10 in old age would lead to even higher levels of CHOP10. In the aged RNase L À/À mice, this cumulative effect would increase hyperplasia of adipose tissue at the expense of its terminal differentiation and efficient lipids storage.
Interestingly, Tomaru et al. 33 recently produced a transgenic mouse with decreased proteasomal chymotrypsin-like activity. These mice overexpressed RNase L and presented a loss of adipose tissue.
Here, we identify RNase L as a regulator of adipogenesis by regulating CHOP10 mRNA stability. As cited above and demonstrated in vivo by others, CHOP10 has a main role in the regulation of adipose tissue expansion by controlling the proliferation phase of preadipocytes. The decrease of RNase L activity, through excessive CHOP10 expression could lead to high preadipocytes proliferation (hyperplasia) and impairment of their terminal differentiation. RNase L activity could be crucial in the control of adipose tissue development and function during obesity and aging; based on our results we propose here a scheme of the role of RNase L in adipogenesis ( Figure 8D ). Cell culture -induction of adipocyte differentiation. WT-MEFs and RNase L À/À -MEFs were cultured, as described previously, in the growth medium (GM): DMEM with 10% (V/V) FCS, 100 U/ml penicillin and 100 mg/ml streptomycin at 371C. 18 At 80% confluence, cells were switched to adipocyte differentiating medium (ADM): GM supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 mM dexamethasone and 10 mM insulin (all from Sigma-Aldrich, Saint-Quentin Fallavier, France) for 2 days. Cells were then incubated in fresh ADM for 2 supplementary days and then the medium was changed to GM for 2 days. 19 For insulin response, cells were treated or not with insulin (1 nmol) for 10 min at 37 1C. Cells were then washed twice with PBS and lysed in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (300 mM Tris (pH 8.9), 5% (W/V) SDS, 750 mM b-mercaptoethanol, 20% (V/V) glycerol and bromophenol blue) for proteins analysis by western blot.
Oil red O labeling -immunofluorescence. Adipogenic cell phenotype was characterized by specific oil red O staining of lipids. 35 Cells were observed with a Nikon AZ100 and TIFF images were captured with a Nikon Digital Camera (DXM 1200c; Champigny sur Marne, France) with ACT-1C program for the control of DXM 1200C platform. Lipids accumulation was quantified by spectrophotometric analysis at 540 nm after eluting the oil red O retained in the cells with ethanol. Optical density was measured with an Infinite 200PRO TECAN.
For immunofluorescence analysis, cells were fixed in 3.7% (V/V) formalin for 10 min and permeabilized with PBS-Triton X100 0.5% (V/V) at room temperature for 5 min. After blocking with 10% (V/V) FCS in PBS, cells were incubated with an antiperilipin or an anti-aP2/Fabp4 antibody (both from Cell Signaling, Ozyme, Saint-Quentin Yvelines, France) for 1 h at room temperature. Cells were then washed and incubated with a donkey anti-rabbit secondary antibody conjugated to tetramethylrhodamine-5,6-isothiocyanate (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at room temperature. Cells were observed at room temperature with an Imager MI Zeiss (Le Pecq, France), and TIFF images were captured with an Axiocam MRm Zeiss and the Axiovision 4.7 (05-2008) program. Semi-quantitative PCR of the cDNAs was performed using a Biometra thermocycler (LABGENE, Archamps, France) in a total volume of 25 ml. Cycle number was 32. Amounts of cDNA were adjusted for each primer pair to be in the linear range amplification and to give the same quantity of amplified cDNA with eukaryotic elongation factor 1a (EEF1a) primers. PCR products were visualized in 1.2% agarose gel and stained with ethidium bromide. Photographies of the gels were captured as TIFF files with a Vilber Lourmat camera and Ecapt program (both from VWR, Fontenay-sous-bois, France).
To quantify genes expression allowing a comparison between WT-MEFs and RNaseL À/À mouse, CHOP10 expression is maintained after induction of differentiation. Consequently, clonal expansion of preadipocytes is more important in RNase L À/À mice that leads to an important adipose tissue development but with less differentiated adipocytes. These adipocytes are not able to stock correctly lipids as do WT mouse adipocytes Gene sequences for primer design were obtained from the NCBI Reference Sequences database. Primers were chosen using the Primer3 and the LightCycler Probe Design (Roche) softwares. When possible, forward and reverse primers were designed on different exon sequences. Primers sequences are provided in Supplementary Table 1. mRNPs immunoprecipitation. We used the protocol described by Sanchez et al. 36 with some modifications. Briefly, confluent WT-MEFs and RNase L À/À -MEFs were lysed with IPP50 buffer (10 mM Tris-HCl (pH 8), 150 mM NaCl,) without NP40 and supplemented with 2 mM EDTA and 10 mg/ml aprotinin, 150 mg/ml leupeptin, 1 mM phenylmethanesulfonyl fluoride and 80U RNaseOut (Invitrogen). Cell extracts were centrifuged at 10 000 Â g. Supernatants (2 mg of proteins) were incubated with protein A-sepharose equilibrated in the same modified IPP50 buffer, and no antibody, mouse monoclonal anti-a-tubulin (SigmaAldrich) or mouse monoclonal anti-RNase L antibody (Abcam, Paris, France). After an overnight incubation at 4 1C with gentle shaking, protein A-sepharose beads were centrifuged and washed three times with ice-cold-modified IPP50 buffer. The pellet was separated in two fractions. One fraction was analyzed for RNase L protein content by western blot as described below. RNAs were extracted from the other fraction by adding TRIzol (1 ml) to the beads and following the manufacturer instructions (Invitrogen). Glycogen (10 mg) was added to ease RNA precipitation with isopropanol. cDNA was generated from total extracted RNA by RT with oligo-(dT) primers and the M-MLV Reverse Transcriptase (Jena Bioscience) as described above. 2.5 ml of RT product was amplified with specific CHOP10 primers (Supplementary Table 1 ) by q-PCR following the manufacturer instructions (Roche) with a LightCycler 480 as described previously.
mRNA stability. WT-MEFs and RNase L À/À -MEFs were plated in GM and, at confluence, cells were treated with actinomycin D (5 mg/ml) for 0, 1, 2, 4 or 6 h. Then RNAs were extracted and analyzed after RT by semi-quantitative PCR as described above. Following agarose gel electrophoresis, pictures of the gels were saved as TIFF files with a Vilber Lourmat camera and Ecapt program. cDNAs were also analyzed by q-PCR following the manufacturer instructions (Roche) with a LightCycler 480 as described above.
Western blot assay. At confluence, cells were switched to differentiation medium as indicated above. Cells were then collected in SDS-PAGE buffer at confluence or after 6 days in ADM. Protein extracts were incubated with benzonase (Sigma-Aldrich) 15 min at 37 1C before western blot analysis. Nitrocellulose membranes were then incubated in blocking buffer for fluorescent western blotting (Odyssey Infrared Imaging System LI-COR Biosciences, ScienceTec, Courtaboeuf, France) for 1 h and incubated with a rabbit polyclonal anti-RLI antibody (Novus Biological, Interchim, Montluçon, France), or a mouse monoclonal anti-Hu-RNase L (Abcam) or a rabbit polyclonal anti-mouse RNase L (Santa Cruz), or a rabbit polyclonal anti-phospho-Akt (Ser 473 ) or a rabbit polyclonal anti-Akt (both from Cell Signaling), or a mouse monoclonal anti-a-tubulin (Sigma-Aldrich) in the same buffer overnight at 4 1C. Membranes were washed in PBS supplemented with 0.05% (V/V) Tween 20 then with PBS alone and incubated for 45 min at room temperature with a donkey anti-rabbit or anti-mouse conjugated to IRDye 700DX or IRDye800 (Rockland, Tebu-Bio). Specific proteins were visualized with a LI-COR Odyssey Biosciences Imaging System. Protein bands were quantified by image analysis with the ImageJ software (http://rsbweb.nih.gov/ij/index.html). -MEFs. 37 After differentiation, cells were incubated 10 min with or without insulin (1 nmol) then medium was changed to glucose-free DMEM and 6-NBDG (300 mM) was then added to all cells for 45 min at 37 1C. Cells were thoroughly washed to remove all exogenous fluorescent glucose analog, and fluorescence intensity of 6-NBDG was measured at 540 nm wavelength (465 nm excitation wavelength) with an Infinite 200PRO TECAN. Fluorescence level was normalized with cell number.
ROS production in WT-MEFs and RNase L À/À -MEFs. ROS level was measured using the nitroblue tetrazolium (NBT) assay (Sigma-Aldrich). 38 Cells were incubated for 90 min in DMEM 0.2% (W/V) NBT. Produced formazan was then dissolved in 50% (V/V) acetic acid and the absorbance was determined at 560 nm with an Infinite 200PRO TECAN. Optical density values were normalized by protein levels. Statistical analysis. Means ± S.D.'s were calculated and statistical analyses using the Holm-Sidak method were performed with the SigmaStat software. Significant differences between two groups are considered for *Pr0.05, **Pr0.01 and y Pr0.001.
Histological analysis of white adipose tissue from WT and RNase L À/À mice. Abdominal fat pad was removed from each mouse (two females and two males, 21 weeks aged) and fixed in 10% formalin. Fixed specimens were embedded in paraffin. Sections were then stained with hematoxylin and eosin (H&E). Adipocytes were counted in four different sections for each mouse.
Phenotype of mouse RNase L À/À . Eight pairs of age-matched WT and RNase L À/À male mice (C57BL/6 strain) were maintained for 18 months and fed with chew diet. Food intake was similar for both types of mice. The average body weight was measured in WT mice (five survived) and in RNase L À/À (six survived). For histological analyses of the liver and kidney, tissues were fixed in formalin and then embedded in paraffin. Sections were deparaffinized, rehydrated and stained with H&E.
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